Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-17T19:13:04.268Z Has data issue: false hasContentIssue false

How Can We Stem the Rising Tide of Multidrug-Resistant Gram-Negative Bacilli?

Published online by Cambridge University Press:  02 January 2015

Lisa L. Maragakis*
Affiliation:
Johns Hopkins University School of Medicine, Baltimore, Maryland
Trish M. Perl
Affiliation:
Johns Hopkins University School of Medicine, Baltimore, Maryland
*
Johns Hopkins University School of Medicine, 600 North Wolfe Street, Osier 425, Baltimore, MD 21287 ([email protected])

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Hidron, AI, Edwards, JR, Patel, J, et al; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare associated infections. Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 [published correction appears in Infect Control Hosp Epidemiol 2009;30(1):107]. Infect Control Hosp Epidemiol 2008;29(11:996-1011.Google Scholar
2. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed January 17, 2010.Google Scholar
3. Harris, AD, McGregor, JC, Furano, JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006;43(suppl 2):S57S61.Google Scholar
4. Weintrob, AC, Roediger, MP, Barber, M, et al. Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized Patients. Infect Control Hosp Epidemiol 2010;31(4:330337 (in this issue).Google Scholar
5. Maragakis, LL, Tucker, MG, Miller, RG, Carroll, KC, Perl, TM. Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008;299(21:25132514.Google Scholar
6. Scott, P, Deye, G, Srinivasan, A, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007;44(12:15771584.Google Scholar
7. Centers for Disease Control and Prevention (CDC). Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep 2004;53(45:10631066.Google Scholar
8. Davis, KA, Moran, KA, McAllister, CK, Gray, PJ. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 2005;11(8): 12181224.Google Scholar
9. Tien, HC, Battad, A, Bryce, EA, et al. Multi-drug resistant Acinetobacter infections in critically injured Canadian Forces soldiers. BMC Infect Dis 2007;7(1):95.CrossRefGoogle ScholarPubMed